Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin as Primary Vasoconstrictor in Critically Ill Patients
NCT06265259Phase 4Recruiting
- Sponsor
- University of Thessaly
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of vasopressin in Shock, sponsored by University of Thessaly. Started Dec 2023; status: recruiting.
02
Drugs
vasopressin
03
Conditions
Shock
Beyond the preview
Go deeper on NCT06265259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06265259.